Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001903596-24-000339
Filing Date
2024-05-20
Accepted
2024-05-20 17:21:04
Documents
44
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 ludg_10q.htm   iXBRL 10-Q 573958
2 ex31_1.htm EX-31.1 9461
3 ex31_2.htm EX-31.2 9320
4 ex32_1.htm EX-32.1 6647
  Complete submission text file 0001903596-24-000339.txt   2962704

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ludg-20240513.xsd EX-101.SCH 27487
6 XBRL CALCULATION FILE ludg-20240513_cal.xml EX-101.CAL 26374
7 XBRL DEFINITION FILE ludg-20240513_def.xml EX-101.DEF 41195
8 XBRL LABEL FILE ludg-20240513_lab.xml EX-101.LAB 164954
9 XBRL PRESENTATION FILE ludg-20240513_pre.xml EX-101.PRE 123311
48 EXTRACTED XBRL INSTANCE DOCUMENT ludg_10q_htm.xml XML 501246
Mailing Address 3160 NW 1 AVENUE POMPANO BEACH FL 33064
Business Address 3160 NW 1 AVENUE POMPANO BEACH FL 33064 786-235-9026
LUDWIG ENTERPRISES, INC. (Filer) CIK: 0001960262 (see all company filings)

EIN.: 611133438 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41881 | Film No.: 24965911
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)